Navigation Links
Ceramide can target and kill cancer cells,,

Research by the scientists from Penn State College of Medicine brought to light that injecting ceramide// into the blood stream it is possible to target and kill breast cancer cells.

Ceramide is a natural substance that accumulates in the cancer cells and thus may be used to get better results out of breast cancer treatments. Researchers had used their techniques on mice for successful results.

However injecting ceramide in the usual way into the blood stream can have severe toxic results. Scientists, to overcome this, have used nanotechnology to create capsules of ceramides called liposomes. Such a way makes it easy for the capsules to move in the blood stream and release the ceramides in the tumor cells. This happens as ceramides are, by nature still unknown to scientists, attracted to tumor cells.

The liposome-encased ceramides reaches the tumor cells via the bloodstream. Then it enters the tumor cells through the vasculature, and disrupts the mitochondria of the cells. In mice these bundles of ceramide targets and destroys only breast cancer cells, leaving the surrounding cells healthy and functional.

The results of the study came up in the new issue of the journal Clinical Cancer Research.

Reference: Penn State University, Press Release, May 2005
'"/>




Page: 1

Related medicine news :

1. Ceramide Directs Stem Cells in Embryo
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Enzyme may be target for obesity drugs
4. Scios Inc. targets drug giants in arthritis war
5. Pharmaceutical companies are targeting patients
6. New target for antidiabetic agents identified
7. Multi targeted approach required for suicide prevention in adolescents
8. GPs discontented with 48-hour target
9. Maori diabetes project way off target
10. Microcapsules target cancer cells
11. Indian American Scientist at Work on Multi-targeted Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Announced that ... clinical and commercial support services market) has entered into an agreement on September ... , The PGSD is the first private Dental School to launch an ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... ... ... Health & Safety Institute (HSI) is offering discounted pricing on its Summit ... now until November 30, 2017 to assist with the clean-up efforts from hurricanes Harvey ... and government agencies – whether or not they will be directly involved in the ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom ... Freedom from ADDICTION” is the creation of published author, Bill Miller. Bill ... homeless services, including more than a decade of addiction to prescription drugs. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: